Feb 4 (Reuters) - Novo Nordisk said on Wednesday it will launch some doses of its oral semaglutide for diabetes under the ...

In A Nutshell Metformin, a common diabetes medication costing less than $10 monthly, was linked to 37% fewer cases of progression to intermediate macular degeneration over five years. The study ...

Doctors are finding new hope for people at risk of losing their sight from age-related macular degeneration, or AMD. Research from the University of Liverpool suggests that metformin, a long-used ...

A drug originally developed to treat type 2 diabetes may protect the heart. Early research shows IC7Fc can lower cholesterol, ...

CagriSema’s blood sugar and weight reductions exceeded the company’s blockbuster Wegovy, yet the drug might still struggle to ...

The upgrade follows recent developments at Sentynl Therapeutics, a subsidiary of Zydus Lifesciences, which secured U.S. FDA ...

An experimental drug once known for helping control type 2 diabetes may also fight heart disease. Researchers found IC7Fc ...

Zydus Lifesciences has received tentative approval from the U.S. Food and Drug Administration (U.S. FDA) for diabetes drug Dapagliflozin Tablets, 5 mg and 10 mg, a generic of AstraZeneca ...

A common diabetes medication does not help people with peripheral artery disease (PAD) and without diabetes walk farther, ...

By Dr. Priyom Bose, Ph.D. Large clinical trials and real-world data point to a familiar diabetes drug as a simple, safe way ...